Genpact Limited (G) Expected to Announce Quarterly Sales of $641.60 Million
Equities analysts forecast that Genpact Limited (NYSE:G) will post $641.60 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Genpact Limited’s earnings, with estimates ranging from $633.00 million to $653.08 million. Genpact Limited posted sales of $630.52 million in the same quarter last year, which would indicate a positive year over year growth rate of 1.8%. The business is scheduled to issue its next earnings results after the market closes on Wednesday, August 2nd.
According to Zacks, analysts expect that Genpact Limited will report full-year sales of $641.60 million for the current year, with estimates ranging from $2.66 billion to $2.69 billion. For the next year, analysts forecast that the company will report sales of $2.86 billion per share, with estimates ranging from $2.78 billion to $2.93 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Genpact Limited.
Genpact Limited (NYSE:G) last issued its quarterly earnings results on Thursday, May 4th. The business services provider reported $0.29 EPS for the quarter, meeting the consensus estimate of $0.29. Genpact Limited had a return on equity of 22.24% and a net margin of 10.23%. The firm had revenue of $623 million during the quarter, compared to analysts’ expectations of $614.84 million. During the same period in the prior year, the firm posted $0.31 earnings per share. The business’s quarterly revenue was up 2.2% compared to the same quarter last year.
Several equities research analysts have issued reports on the company. Jefferies Group LLC restated a “buy” rating on shares of Genpact Limited in a research report on Friday, March 17th. Zacks Investment Research raised Genpact Limited from a “hold” rating to a “buy” rating and set a $27.00 target price on the stock in a research note on Friday, April 14th. BMO Capital Markets reissued a “hold” rating and issued a $25.00 target price on shares of Genpact Limited in a research note on Thursday, March 23rd. Finally, BidaskClub raised Genpact Limited from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, June 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Genpact Limited has an average rating of “Buy” and an average target price of $28.38.
Genpact Limited (NYSE G) traded up 1.0232% during mid-day trading on Wednesday, hitting $27.8925. The stock had a trading volume of 182,263 shares. The stock has a market cap of $5.38 billion, a PE ratio of 21.9108 and a beta of 0.50. Genpact Limited has a 1-year low of $22.58 and a 1-year high of $28.27. The firm’s 50-day moving average price is $27.12 and its 200-day moving average price is $25.04.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 28th. Stockholders of record on Monday, June 12th were issued a dividend of $0.06 per share. The ex-dividend date was Thursday, June 8th. This represents a $0.24 annualized dividend and a dividend yield of 0.87%. Genpact Limited’s payout ratio is 18.75%.
In other Genpact Limited news, insider Mohit Thukral sold 27,228 shares of Genpact Limited stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $27.21, for a total value of $740,873.88. Following the completion of the sale, the insider now owns 68,845 shares of the company’s stock, valued at approximately $1,873,272.45. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director James C. Madden sold 5,224 shares of Genpact Limited stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $25.51, for a total transaction of $133,264.24. Following the completion of the sale, the director now directly owns 8,970 shares of the company’s stock, valued at approximately $228,824.70. The disclosure for this sale can be found here. 1.55% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Fifth Third Bancorp increased its position in shares of Genpact Limited by 1.2% in the first quarter. Fifth Third Bancorp now owns 9,976 shares of the business services provider’s stock worth $247,000 after buying an additional 121 shares in the last quarter. Ngam Advisors L.P. boosted its stake in Genpact Limited by 0.6% in the first quarter. Ngam Advisors L.P. now owns 38,866 shares of the business services provider’s stock worth $962,000 after buying an additional 242 shares during the last quarter. Genesee Valley Trust Co. boosted its stake in Genpact Limited by 3.0% in the first quarter. Genesee Valley Trust Co. now owns 13,947 shares of the business services provider’s stock worth $345,000 after buying an additional 405 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Genpact Limited by 3.0% in the first quarter. Envestnet Asset Management Inc. now owns 34,564 shares of the business services provider’s stock worth $855,000 after buying an additional 994 shares during the last quarter. Finally, Bank of Montreal Can boosted its stake in Genpact Limited by 1.2% in the first quarter. Bank of Montreal Can now owns 117,378 shares of the business services provider’s stock worth $2,906,000 after buying an additional 1,379 shares during the last quarter. Institutional investors and hedge funds own 93.94% of the company’s stock.
About Genpact Limited
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.